Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05522153 · ClinicalTrials.gov registry record · Phase 1
Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study
A Phase 1 study, sponsored by Virtua Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 61
- Enrollment target
NCT05522153 is a Phase 1 study that has completed, run by Virtua Health. The registered enrollment target is 61 participants.
The verdict
NCT05522153, a Phase 1 study, has completed, sponsored by Virtua Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 61 participants
- Enrollment target
Study Summary
To examine in Arista hemostatic powder results in less post-total knee arthroplasty blood loss, hematoma formation, and improved range of motion when compared to patients who did not receive the product.
Interventions
- DRUG Arista
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2023-06-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05522153
The ClinicalTrials.gov registry entry for NCT05522153 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virtua Health, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Arista is the first listed.
NCT05522153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05522153 about?
NCT05522153 is a clinical study titled "Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study". To examine in Arista hemostatic powder results in less post-total knee arthroplasty blood loss, hematoma formation, and improved range of motion when compared to patients who did not receive the product.
What is the current status of trial NCT05522153?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 61 participants. The study started on 2021-05-01. Estimated completion is 2023-06-08.
What interventions are being tested in trial NCT05522153?
The interventions under investigation include: Arista (DRUG).
Who is sponsoring clinical trial NCT05522153?
This trial is sponsored by Virtua Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.